Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Dick's Sporting Goods

Lowe's

Michaels

Target

Americans feel a bit confident now about the labor market and the overall economic environment. Michaels (MIK), Rite Aid (RAD), DICK'S Sporting (DKS), Target (TGT) and Lowe's (LOW) will be a great addition to your portfolio.

5 Retail Stocks in Focus as Americans Look Confident Now

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is further expanding its no-charge COVID-19 testing capabilities with 60 additional drive-through locations opening on Friday, January 22, through its partnership with the U.S. Department of Health and Human Services (HHS). Additionally, no-charge testing will now be available for ages four and older at all new and existing drive-through testing sites. Previously, testing had been available to individuals 13 years of age and older. The new l

Rite Aid Expands No-Charge COVID-19 Testing to 460 Drive-Through Locations

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Rite Aid (RAD) Down 9.1% Since Last Earnings Report: Can It Rebound?

Rite Aid Corporation (RAD) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: Rite Aid (RAD)

Rite Aid (RAD) remains poised for solid growth ahead, driven by strength in online services, PBM market and Elixir.

Here's Why Rite Aid (RAD) Marching Ahead of the Industry

Rite Aid Corporation (RAD) CEO Heyward Donigan Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)

Rite Aid has given more than 5,000 Covid vaccations so far and it's seen the rollout's challenges firsthand, its CEO said.

Rite Aid CEO said retailers will get tapped sooner than expected to help speed vaccine rollout

CVS Health

Walgreens

The three drugstore chains have expanded their digital offerings and stepped up their focus on health and wellness to keep up with consumer preferences.

Covid vaccinations offer CVS, Walgreens and Rite Aid a chance to showcase how drugstores have changed

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) announced today that Heyward Donigan, president and chief executive officer; Jim Peters, chief operating officer and Matt Schroeder, executive vice president and chief financial officer will participate in a fireside chat with investors at the 39th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 11th at approximately 11:40 a.m. ET. The conference is a virtual event. The appearance will be broadcast via the Internet at ht

Rite Aid to Present at the 39th Annual J.P. Morgan Healthcare Conference

American Airlines

Continental Resources

Stitch Fix

Virgin Galactic

SunPower

Bed Bath & Beyond

Short squeezes can fuel massive rallies in just a couple of days, making these some of the best stocks to buy when timed correctly. The post 7 Best Stocks to Buy for a Potential Short Squeeze appeared first on InvestorPlace.

7 Best Stocks to Buy for a Potential Short Squeeze

Investors need to pay close attention to Rite Aid (RAD) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Rite Aid (RAD) Stock?

Is (RAD) Outperforming Other Retail-Wholesale Stocks This Year?

Has Rite Aid (RAD) Outpaced Other Retail-Wholesale Stocks This Year?

Beacon Roofing Supply

MarineMax

Consumer confidence declined for the second successive month in December. But these retailers - DICK'S Sporting (DKS), Beacon Roofing Supply (BECN), MarineMax (HZO), Rite Aid (RAD) Target (TGT) - could still be a great addition to your portfolio.

Don't Lose Confidence, Scoop Up These 5 Retail Stocks Instead

99 new locations are to come on line Tuesday.

Rite Aid Expanding Free Drive-Thru Coronavirus Testing

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) is further expanding its no-charge COVID-19 testing capabilities with 99 additional drive-through locations opening on Tuesday, December 22 through its partnership with the U.S. Department of Health and Human Services (HHS). Rite Aid's COVID-19 testing service will expand coast-to-coast, with new locations in California, Nevada, Washington, Michigan, Ohio, Pennsylvania, Virginia, New York, Connecticut, New Jersey, Delaware, and Maryland. Lik

Rite Aid Expands No-Charge COVID-19 Testing to 400 Drive-Through Locations

Rite Aid's (RAD) Q3 results gain from solid demand, rise in same-store prescription count, strength in Elixir brand and robust online growth. Also, it is progressing well with RxEvolution strategy.

Rite Aid (RAD) Soars on Earnings & Revenues Beat in Q3

The coronavirus didn't exactly have a damaging effect on the pharmacy chain.

Rite Aid Posts Surprise Q3 Profit

Seeking Alpha Transcripts | Services Rite Aid Corporation (RAD) CEO Heyward Donigan on Q3 2021 Results - Earnings Call Transcript Dec. 17, 2020 1:31 PM ET | | About: Rite Aid Corporation (RAD) by: SA Transcripts Subscribers Only Earning Call Audio Rite Aid Corporation (NYSE:RAD) Q3 2021 Earnings Conference Call December 17, 2020 8:30 AM ET Company Participants Trent Kruse - VP of IR and Treasury Heyward Donigan - CEO

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q3 2021 Results - Earnings Call Transcript

Lennar

Markets are climbing, and earnings reports from these companies have a lot to do with it.

These 2 Stocks Have Stock Market Investors Excited About 2021

Rite Aid Corporation reported on Thursday (Dec. 17) as part of its Fiscal 2021 Q3 results that revenues rose 12 percent, fueled by expansion in the retail pharmacy and pharmacy services areas. Revenues from continuing operations for the timeframe were $6.12 billion, up from $5.46 billion in the past year's quarter, according to an announcement.

Rite Aid Reports 12 Pct Rise In Revenues

The pharmacy company reported very good Q3 results.

Why Rite Aid Stock Is Rocking Today

Rite Aid Corp. is partnering with the Centers for Disease Control and Prevention in helping administer COVID-19 vaccines.

Rite Aid partners with CDC on COVID-19 vaccine as profits soar

RiteAid (RAD) is seeing an increase in RAD stock on Thursday following the release of the pharmacy company's fiscal Q3 2021 earnings report. The post RAD Stock: 14 Reasons Why RiteAid Is Rocketing Higher Today appeared first on InvestorPlace.

RAD Stock: 14 Reasons Why RiteAid Is Rocketing Higher Today

The shares of Rite Aid Corporation (NYSE:RAD) are surging, last seen up 25% to a new annual high of $21.39, after the pharmacy giant scored an unexpected quarterly profit.

Rite Aid Stock Soars to Annual High on Surprise Top-Line beat

Rite Aid (RAD) delivered earnings and revenue surprises of 4100.00% and 4.63%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

News for Rite Aid Stock (RAD)